Glioblastoma (GBM) is the most invasive and devastating primary brain tumor with a median
overall survival rate about 18 months with aggressive multimodality therapy. Its unique …

Glioma is one of the most commonly diagnosed brain malignancies with a high cancer-
related death rate in humans. The prognosis of glioma patients is still unsatisfactory. In the …

Simple Summary Glioblastoma (GBM) is one of the most malignant types of central nervous
system tumor which accounts for more than 60% of all brain tumors in adults. Owing to poor …

High mobility group box 3 (HMGB3) is strongly involved in oncogenesis in a variety of
cancers. In the present study, we have explored the role of HMGB3 in glioblastoma …

Chemotherapy is an important treatment option for gastric cancer (GC); however,
chemotherapy usually fails due to drug resistance, particularly multidrug resistance (MDR) …

Because circulating microRNAs (miRNAs) have drawn a great deal of attention as promising
novel cancer diagnostics and prognostic biomarkers, we sought to identify serum miRNAs …

MicroRNAs (miRNAs) are key regulatory elements encoded by the genome. A single miRNA
can downregulate the expression of multiple genes involved in diverse functions. Because …

Glioblastoma (GBM) is the most common malignant brain tumor. Available treatments have
limited success because most patients develop chemoresistance. Alternative strategies are …

Simple Summary The overall survival of brain cancer patients remains grim, with
conventional therapies such as chemotherapy and radiotherapy only providing marginal …

Despite advances in novel therapeutic approaches for the treatment of glioblastoma (GBM),
the median survival of 12-14 months has not changed significantly. Therefore, there is an …